The largest database of trusted experimental protocols

8 protocols using ly294002 ly

1

Inhibition of Akt and Erk1/2 Kinases

Check if the same lab product or an alternative is used in the 5 most similar protocols
To inhibit the activation of Akt and Erk1/2, two of the major kinases involved in the RISK pathway, SCR and OX-Neu3 H9c2 cells were treated with two specific commercially available inhibitors. In particular, LY294002 (LY; Cell Signaling Technology, Danvers, MA, USA), which is a potent cell permeable inhibitor of the phosphatidylinositol 3-kinase (PI3K), is able to block the PI3K-dependent Akt phosphorylation. PD98059 (PD; Cell Signaling Technology), which is instead a highly selective inhibitor of the Mek1 activation and of the MAP kinase cascade, was used to block Erk phosphorylation on both threonine and tyrosine residues. Both inhibitors were used at a 50 μM concentration. OX-Neu3 and SCR cells were incubated with both inhibitors 1 h before being exposed to IRI and during the entire duration of the experiments.
+ Open protocol
+ Expand
2

Oxidative Stress Modulation in A549 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
A549 cells (Procell, Wuhan, China) were cultured in Dulbecco’s Modified Eagle’s Medium (DMEM) (Gibco, Rockville, MD, USA) containing 10% fetal bovine serum (FBS) (Gibco, Rockville, MD, USA) and 1% penicillin/streptomycin (Gibco, Rockville, MD, USA), in a cell incubator containing 5% CO2 at 37°C. The cell medium was changed once a day and cell passage was performed when the cell confluence reached about 80%. To induce oxidative stress in cells, H2O2 was used to treat the A549 cells for 24 hours. The DHCR24 overexpression plasmid was constructed by Shanghai Genechem Co., LTD. (Shanghai, China) and transfected into A549 cells using Lipofectamine™ 3000 (Invitrogen, Carlsbad, CA, USA) according to the instructions. To inhibit the PI3K/AKT signaling pathway, PI3K inhibitor LY294002 (LY) (Cell Signaling Technology, Danvers, MA, USA) was utilized to treat A549 cells according to the protocols.
+ Open protocol
+ Expand
3

Inhibition of PI3K-Akt and Cell Death Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
For the infection experiments in which the PI3K-Akt pathway or cell death proteins were inhibited, dimethyl sulfoxide (DMSO; from ATCC) was used as a vehicle control at a final concentration of 0.5% in cell culture media. LY294002 (LY; #9901 from Cell Signaling Technology) was used to inhibit the PI3K-Akt pathway at a final concentration of 50 µM, and it was added to the cells 1-2 hours before the infection. LY294002 has been demonstrated previously to function as a highly selective inhibitor of PI3K. When it is used at a concentration of 50 μM with a pre-treatment period of at least 1 hour (as it was in our studies), it is able to specifically abolish PI3K activity (IC50 = 0.43 μg/ml; 1.40 μM) (Vlahos et al., 1994 (link)). Of note, it does not inhibit other similar lipid and protein kinases, including PI4K, c-Src, MAPK, and PKC (Vlahos et al., 1994 (link)). Z-VAD-fmk (ApexBio) was used as a pan caspase inhibitor at a final concentration of 50 µM, and it was also added to cells 1-2 hours before the infection.
+ Open protocol
+ Expand
4

Cell Migration Assay for SH-SY5Y Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Migration of SH-SY5Y cells was carried out using the Ibidi Culture-Inserts assay (2 × 0.22 cm2; Ibidi, Regensburg, Germany) following the manufacturer’s instructions. Three hundred thousand cells were seeded on the culture-inserts. After 24 h, inserts were carefully removed and migration was analyzed using a BDS200 inverted microscope (Optec, Chongqing, China) at time 0 (insert removal) or following 24 and 48 h of EV treatment. To study the effects of AKT inhibition, cells were pre-treated with 10 μM of LY294002 (LY) (Cell Signaling Technology, Inc., Danvers, MA, USA) 1 h before EV treatment, and added every 24 h during medium refreshment. The migration rate was determined by analyzing the cell-free area with ImageJ Analysis Software 1.50i (National Institutes of Health, Bethesda, MD, USA).
+ Open protocol
+ Expand
5

Stress Response in Thyroid Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human thyroid follicular epithelial Nthy-ori 3-1 cells, obtained from European Collection of Authenticated Cell Cultures (ECACC 90011609) (Public Health England, Porton Down, Salisbury, UK) (Sigma Aldrich, St. Louis, MO, USA) were cultured at 37 °C in RPMI 1640 medium containing 10% fetal bovine serum (FBS), 100 U/mL penicillin/streptomycin and 2 mM L-glutamine. Human thyroid cancer cell lines, TPC-1 (harboring RET-PTC rearrangement, BRAF WT/WT), characterized according to Schweppe et al., and kindly provided by A. Coppa (Department of Experimental Medicine, Sapienza University of Rome, Rome), were maintained in a 5% CO2 culture humidified atmosphere, at 37 °C in Dulbecco’s modified Eagle medium (DMEM) supplemented with 10% FBS [29 (link)]. For experiments, cells were seeded and at sub-confluence (70%), were starved overnight using medium with 0.2% FBS, in order to reduce basal cellular activity [30 (link),31 (link)]. Then, the cells were stressed by H2O2 (Sigma-Aldrich, Milan, Italy) alone or combined with EGF (human recombinant, Sigma Aldrich) or MAPK and AKT inhibitors (PD98059 and LY294002, respectively). In particular, the cells were pretreated with 50 ng/mL EGF for 15 min or with PD98059 (PD) at 50 μM and LY294002 (LY) at 25 μM (Cell Signaling Technology, Beverly, MA, USA) for 1 h and then stressed by a supra-physiological H2O2 concentration added to the external medium.
+ Open protocol
+ Expand
6

Endothelial Cell Signaling Pathway Regulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
FSH (#F4021), 17β-estradiol (E2, #E2758), TNF-α(#T0157), pertussis toxin (PTX, #3097), β-methyl cyclodextrin (β-MCD, #C-4555), and KU0063794 (#SML0382) were purchased from Sigma Aldrich (St. Louis, MO, USA). 4-amino-5-(4-chlorophenyl)-7-(t-butyl) pyrazolo (3,4-d) pyrimidine (PP2, #1407), pyrrolidine dithiocarbamate (PDTC, #0727), PD98059 (#1213), NF499 (#1391), forskolin (#1099), MDL12330A(#1436) were obtained from Tocris Bioscience (Minneapolis, MN, USA). LY294002 (LY, #9901s) and H89 (#9844s) were acquired from Cell Signaling Technologies (CST, Beverly, MA, USA). Endothelial Basal Medium-2 (EBM-2) (#190860) was purchased from Lonza (Walkersville, MD, USA). Opti-MEM (#31985) and fetal bovine serum (FBS, #12484) were obtained from Invitrogen (Carlsbad, CA, USA). All other chemicals were of analytical grade and purchased from Guangzhou Chemical Reagents (Guangzhou, China).
+ Open protocol
+ Expand
7

Evaluating HCC Cell Line Responses to Inhibitor Treatments

Check if the same lab product or an alternative is used in the 5 most similar protocols
The HCC cell lines HepG2, Hep3B, Huh7, PLC/PRF/5, HepG2-Luc(+) and Hep3B-Luc(+) were maintained in high-glucose DMEM supplemented with 10% fetal bovine serum (Invitrogen, Carlsbad, CA), and 1% penicillin-streptomycin. The cells were incubated in a humidified atmosphere containing 5% CO2 at 37°C. Where appropriate, cells were treated with the chemicals LY294002 (LY) (Cell Signaling Technology Inc., Danvers, MA) [33 (link)]; or Cns-A (Cytosporone A n-amyl ester, compound 10i) (Sigma-Aldrich, St. Louis, MO) [26 (link)] at 10 μM final concentration, for 48 hours.
+ Open protocol
+ Expand
8

Osteogenic Differentiation Assays

Check if the same lab product or an alternative is used in the 5 most similar protocols
Recombinant BMP2 was purchased from R&D Systems (Minneapolis, MN, USA). The RealTime-Glo™ MT Cell Viability Assay Kit was purchased from Promega Corporation (Madison, WI, USA). PD98059 (PD), LDN193189 dihydrochloride (LDN), and SB202190 (SB) were purchased from Tocris Biosciences (Bristol, UK). LY294002 (LY) was obtained from Cell Signaling Technology (Danvers, MA, USA) and Mitomycin C (MC) was from Cayman Chemical Company (Ann Arbor, MI, USA). Recombinant mouse ALP and mouse OCN ELISA kits were obtained from Novus Biologicals (Centennial, CO, USA). p-N-Phenyl-Phosphate Substrate (p-NPP) was purchased from Life Technologies (Fredrick, MD, USA). Alizarin Red S was procured from Sigma Aldrich (St. Louis, MO, USA). Horseradish peroxidase (HRP)-conjugated goat antirabbit IgG (#sc-2004) was obtained from Santa Cruz Biotechnology Inc. (Dallas, TX, USA). HRP-conjugated goat anti-mouse IgG (#115035068) was obtained from Jackson ImmunoResearch Laboratories (West Grove, PA, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!